nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—Alzheimer's disease	0.174	1	CbGaD
Oxymorphone—Oxycodone—Galantamine—Alzheimer's disease	0.134	0.271	CrCrCtD
Oxymorphone—Dihydrocodeine—Galantamine—Alzheimer's disease	0.125	0.253	CrCrCtD
Oxymorphone—Morphine—Galantamine—Alzheimer's disease	0.125	0.253	CrCrCtD
Oxymorphone—Hydrocodone—Galantamine—Alzheimer's disease	0.11	0.223	CrCrCtD
Oxymorphone—CYP2D6—Rivastigmine—Alzheimer's disease	0.0557	0.264	CbGbCtD
Oxymorphone—CYP2D6—Donepezil—Alzheimer's disease	0.0445	0.211	CbGbCtD
Oxymorphone—CYP3A4—Rivastigmine—Alzheimer's disease	0.0354	0.168	CbGbCtD
Oxymorphone—CYP2D6—Galantamine—Alzheimer's disease	0.0287	0.136	CbGbCtD
Oxymorphone—CYP3A4—Donepezil—Alzheimer's disease	0.0283	0.134	CbGbCtD
Oxymorphone—CYP3A4—Galantamine—Alzheimer's disease	0.0182	0.0865	CbGbCtD
Oxymorphone—OPRM1—telencephalic ventricle—Alzheimer's disease	0.00342	0.208	CbGeAlD
Oxymorphone—OPRD1—forebrain—Alzheimer's disease	0.00131	0.0796	CbGeAlD
Oxymorphone—OPRK1—forebrain—Alzheimer's disease	0.00125	0.0763	CbGeAlD
Oxymorphone—OPRD1—telencephalon—Alzheimer's disease	0.0012	0.0732	CbGeAlD
Oxymorphone—Naloxone—CREB1—Alzheimer's disease	0.00108	0.425	CrCbGaD
Oxymorphone—OPRM1—forebrain—Alzheimer's disease	0.000893	0.0543	CbGeAlD
Oxymorphone—OPRM1—telencephalon—Alzheimer's disease	0.000821	0.0499	CbGeAlD
Oxymorphone—OPRD1—nervous system—Alzheimer's disease	0.000711	0.0432	CbGeAlD
Oxymorphone—OPRD1—central nervous system—Alzheimer's disease	0.000684	0.0416	CbGeAlD
Oxymorphone—OPRK1—nervous system—Alzheimer's disease	0.000681	0.0414	CbGeAlD
Oxymorphone—OPRK1—central nervous system—Alzheimer's disease	0.000656	0.0399	CbGeAlD
Oxymorphone—OPRK1—cerebellum—Alzheimer's disease	0.000641	0.039	CbGeAlD
Oxymorphone—OPRD1—brain—Alzheimer's disease	0.000543	0.033	CbGeAlD
Oxymorphone—OPRK1—brain—Alzheimer's disease	0.000521	0.0317	CbGeAlD
Oxymorphone—OPRM1—nervous system—Alzheimer's disease	0.000485	0.0295	CbGeAlD
Oxymorphone—OPRM1—central nervous system—Alzheimer's disease	0.000467	0.0284	CbGeAlD
Oxymorphone—Menopausal symptoms—Memantine—Alzheimer's disease	0.00045	0.00508	CcSEcCtD
Oxymorphone—Urinary retention—Donepezil—Alzheimer's disease	0.000445	0.00502	CcSEcCtD
Oxymorphone—Hot flush—Rivastigmine—Alzheimer's disease	0.000444	0.00501	CcSEcCtD
Oxymorphone—Amnesia—Rivastigmine—Alzheimer's disease	0.000442	0.00499	CcSEcCtD
Oxymorphone—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.00044	0.00497	CcSEcCtD
Oxymorphone—Dehydration—Donepezil—Alzheimer's disease	0.000435	0.00491	CcSEcCtD
Oxymorphone—Lethargy—Memantine—Alzheimer's disease	0.000434	0.00489	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000427	0.00482	CcSEcCtD
Oxymorphone—Bradycardia—Galantamine—Alzheimer's disease	0.000425	0.00479	CcSEcCtD
Oxymorphone—Diplopia—Memantine—Alzheimer's disease	0.000425	0.00479	CcSEcCtD
Oxymorphone—Diplopia—Rivastigmine—Alzheimer's disease	0.000416	0.00469	CcSEcCtD
Oxymorphone—Hallucination—Galantamine—Alzheimer's disease	0.000416	0.00468	CcSEcCtD
Oxymorphone—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000412	0.00465	CcSEcCtD
Oxymorphone—Urethral disorder—Galantamine—Alzheimer's disease	0.000409	0.00462	CcSEcCtD
Oxymorphone—Abdominal distension—Donepezil—Alzheimer's disease	0.000407	0.00459	CcSEcCtD
Oxymorphone—Urinary retention—Memantine—Alzheimer's disease	0.000404	0.00455	CcSEcCtD
Oxymorphone—Visual impairment—Galantamine—Alzheimer's disease	0.000403	0.00454	CcSEcCtD
Oxymorphone—Urinary retention—Rivastigmine—Alzheimer's disease	0.000395	0.00445	CcSEcCtD
Oxymorphone—Dehydration—Memantine—Alzheimer's disease	0.000395	0.00445	CcSEcCtD
Oxymorphone—Sweating increased—Donepezil—Alzheimer's disease	0.000394	0.00444	CcSEcCtD
Oxymorphone—Eye disorder—Galantamine—Alzheimer's disease	0.00039	0.0044	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000388	0.00437	CcSEcCtD
Oxymorphone—Cardiac disorder—Galantamine—Alzheimer's disease	0.000388	0.00437	CcSEcCtD
Oxymorphone—Flushing—Galantamine—Alzheimer's disease	0.000388	0.00437	CcSEcCtD
Oxymorphone—Dehydration—Rivastigmine—Alzheimer's disease	0.000387	0.00436	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00038	0.00428	CcSEcCtD
Oxymorphone—Angiopathy—Galantamine—Alzheimer's disease	0.000379	0.00427	CcSEcCtD
Oxymorphone—Immune system disorder—Galantamine—Alzheimer's disease	0.000377	0.00425	CcSEcCtD
Oxymorphone—OPRM1—brain—Alzheimer's disease	0.00037	0.0225	CbGeAlD
Oxymorphone—Mental disorder—Galantamine—Alzheimer's disease	0.000366	0.00412	CcSEcCtD
Oxymorphone—Weight decreased—Donepezil—Alzheimer's disease	0.000366	0.00412	CcSEcCtD
Oxymorphone—Malnutrition—Galantamine—Alzheimer's disease	0.000364	0.0041	CcSEcCtD
Oxymorphone—Pneumonia—Donepezil—Alzheimer's disease	0.000363	0.00409	CcSEcCtD
Oxymorphone—Bronchospasm—Memantine—Alzheimer's disease	0.000361	0.00407	CcSEcCtD
Oxymorphone—Flatulence—Galantamine—Alzheimer's disease	0.000358	0.00404	CcSEcCtD
Oxymorphone—CYP2D6—forebrain—Alzheimer's disease	0.000358	0.0218	CbGeAlD
Oxymorphone—Sweating increased—Memantine—Alzheimer's disease	0.000358	0.00403	CcSEcCtD
Oxymorphone—Tension—Galantamine—Alzheimer's disease	0.000357	0.00402	CcSEcCtD
Oxymorphone—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000353	0.00398	CcSEcCtD
Oxymorphone—Nervousness—Galantamine—Alzheimer's disease	0.000353	0.00398	CcSEcCtD
Oxymorphone—Sweating increased—Rivastigmine—Alzheimer's disease	0.00035	0.00394	CcSEcCtD
Oxymorphone—Vision blurred—Galantamine—Alzheimer's disease	0.000343	0.00386	CcSEcCtD
Oxymorphone—Agitation—Galantamine—Alzheimer's disease	0.000334	0.00377	CcSEcCtD
Oxymorphone—Weight decreased—Memantine—Alzheimer's disease	0.000332	0.00374	CcSEcCtD
Oxymorphone—Bradycardia—Donepezil—Alzheimer's disease	0.00033	0.00371	CcSEcCtD
Oxymorphone—Pneumonia—Memantine—Alzheimer's disease	0.000329	0.00371	CcSEcCtD
Oxymorphone—CYP2D6—telencephalon—Alzheimer's disease	0.000329	0.02	CbGeAlD
Oxymorphone—Vertigo—Galantamine—Alzheimer's disease	0.000327	0.00368	CcSEcCtD
Oxymorphone—Syncope—Galantamine—Alzheimer's disease	0.000326	0.00368	CcSEcCtD
Oxymorphone—Weight decreased—Rivastigmine—Alzheimer's disease	0.000325	0.00366	CcSEcCtD
Oxymorphone—Pneumonia—Rivastigmine—Alzheimer's disease	0.000322	0.00363	CcSEcCtD
Oxymorphone—Hallucination—Donepezil—Alzheimer's disease	0.000322	0.00363	CcSEcCtD
Oxymorphone—Palpitations—Galantamine—Alzheimer's disease	0.000321	0.00362	CcSEcCtD
Oxymorphone—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00032	0.0036	CcSEcCtD
Oxymorphone—Loss of consciousness—Galantamine—Alzheimer's disease	0.00032	0.0036	CcSEcCtD
Oxymorphone—Urethral disorder—Donepezil—Alzheimer's disease	0.000317	0.00358	CcSEcCtD
Oxymorphone—Convulsion—Galantamine—Alzheimer's disease	0.000315	0.00355	CcSEcCtD
Oxymorphone—Hypertension—Galantamine—Alzheimer's disease	0.000314	0.00354	CcSEcCtD
Oxymorphone—Visual impairment—Donepezil—Alzheimer's disease	0.000312	0.00352	CcSEcCtD
Oxymorphone—Chest pain—Galantamine—Alzheimer's disease	0.00031	0.00349	CcSEcCtD
Oxymorphone—Anxiety—Galantamine—Alzheimer's disease	0.000308	0.00348	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000307	0.00347	CcSEcCtD
Oxymorphone—Dry mouth—Galantamine—Alzheimer's disease	0.000303	0.00341	CcSEcCtD
Oxymorphone—Confusional state—Galantamine—Alzheimer's disease	0.000299	0.00337	CcSEcCtD
Oxymorphone—Bradycardia—Memantine—Alzheimer's disease	0.000299	0.00337	CcSEcCtD
Oxymorphone—Bradycardia—Rivastigmine—Alzheimer's disease	0.000293	0.0033	CcSEcCtD
Oxymorphone—Hallucination—Memantine—Alzheimer's disease	0.000292	0.0033	CcSEcCtD
Oxymorphone—Shock—Galantamine—Alzheimer's disease	0.000292	0.00329	CcSEcCtD
Oxymorphone—Nervous system disorder—Galantamine—Alzheimer's disease	0.000291	0.00328	CcSEcCtD
Oxymorphone—Urinary tract disorder—Memantine—Alzheimer's disease	0.00029	0.00327	CcSEcCtD
Oxymorphone—Tachycardia—Galantamine—Alzheimer's disease	0.00029	0.00326	CcSEcCtD
Oxymorphone—Skin disorder—Galantamine—Alzheimer's disease	0.000288	0.00325	CcSEcCtD
Oxymorphone—Urethral disorder—Memantine—Alzheimer's disease	0.000288	0.00325	CcSEcCtD
Oxymorphone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000287	0.00323	CcSEcCtD
Oxymorphone—Hallucination—Rivastigmine—Alzheimer's disease	0.000286	0.00322	CcSEcCtD
Oxymorphone—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000284	0.0032	CcSEcCtD
Oxymorphone—Mental disorder—Donepezil—Alzheimer's disease	0.000284	0.0032	CcSEcCtD
Oxymorphone—Visual impairment—Memantine—Alzheimer's disease	0.000283	0.00319	CcSEcCtD
Oxymorphone—Anorexia—Galantamine—Alzheimer's disease	0.000283	0.00319	CcSEcCtD
Oxymorphone—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000282	0.00318	CcSEcCtD
Oxymorphone—Malnutrition—Donepezil—Alzheimer's disease	0.000282	0.00318	CcSEcCtD
Oxymorphone—Flatulence—Donepezil—Alzheimer's disease	0.000278	0.00313	CcSEcCtD
Oxymorphone—Hypotension—Galantamine—Alzheimer's disease	0.000277	0.00313	CcSEcCtD
Oxymorphone—Visual impairment—Rivastigmine—Alzheimer's disease	0.000277	0.00312	CcSEcCtD
Oxymorphone—Tension—Donepezil—Alzheimer's disease	0.000277	0.00312	CcSEcCtD
Oxymorphone—Eye disorder—Memantine—Alzheimer's disease	0.000275	0.0031	CcSEcCtD
Oxymorphone—Nervousness—Donepezil—Alzheimer's disease	0.000274	0.00309	CcSEcCtD
Oxymorphone—Cardiac disorder—Memantine—Alzheimer's disease	0.000273	0.00307	CcSEcCtD
Oxymorphone—Flushing—Memantine—Alzheimer's disease	0.000273	0.00307	CcSEcCtD
Oxymorphone—Eye disorder—Rivastigmine—Alzheimer's disease	0.000269	0.00303	CcSEcCtD
Oxymorphone—Insomnia—Galantamine—Alzheimer's disease	0.000268	0.00303	CcSEcCtD
Oxymorphone—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000267	0.00301	CcSEcCtD
Oxymorphone—Flushing—Rivastigmine—Alzheimer's disease	0.000267	0.00301	CcSEcCtD
Oxymorphone—Angiopathy—Memantine—Alzheimer's disease	0.000267	0.00301	CcSEcCtD
Oxymorphone—Vision blurred—Donepezil—Alzheimer's disease	0.000266	0.00299	CcSEcCtD
Oxymorphone—Immune system disorder—Memantine—Alzheimer's disease	0.000265	0.00299	CcSEcCtD
Oxymorphone—Mediastinal disorder—Memantine—Alzheimer's disease	0.000265	0.00299	CcSEcCtD
Oxymorphone—Somnolence—Galantamine—Alzheimer's disease	0.000264	0.00297	CcSEcCtD
Oxymorphone—Dyspepsia—Galantamine—Alzheimer's disease	0.000261	0.00294	CcSEcCtD
Oxymorphone—Angiopathy—Rivastigmine—Alzheimer's disease	0.000261	0.00294	CcSEcCtD
Oxymorphone—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000259	0.00292	CcSEcCtD
Oxymorphone—Agitation—Donepezil—Alzheimer's disease	0.000259	0.00292	CcSEcCtD
Oxymorphone—Decreased appetite—Galantamine—Alzheimer's disease	0.000258	0.00291	CcSEcCtD
Oxymorphone—Mental disorder—Memantine—Alzheimer's disease	0.000257	0.0029	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000256	0.00289	CcSEcCtD
Oxymorphone—Malnutrition—Memantine—Alzheimer's disease	0.000256	0.00288	CcSEcCtD
Oxymorphone—Fatigue—Galantamine—Alzheimer's disease	0.000256	0.00288	CcSEcCtD
Oxymorphone—Constipation—Galantamine—Alzheimer's disease	0.000254	0.00286	CcSEcCtD
Oxymorphone—Vertigo—Donepezil—Alzheimer's disease	0.000253	0.00285	CcSEcCtD
Oxymorphone—Syncope—Donepezil—Alzheimer's disease	0.000253	0.00285	CcSEcCtD
Oxymorphone—Flatulence—Memantine—Alzheimer's disease	0.000252	0.00284	CcSEcCtD
Oxymorphone—Mental disorder—Rivastigmine—Alzheimer's disease	0.000252	0.00284	CcSEcCtD
Oxymorphone—Tension—Memantine—Alzheimer's disease	0.000251	0.00283	CcSEcCtD
Oxymorphone—Malnutrition—Rivastigmine—Alzheimer's disease	0.00025	0.00282	CcSEcCtD
Oxymorphone—Nervousness—Memantine—Alzheimer's disease	0.000248	0.0028	CcSEcCtD
Oxymorphone—Loss of consciousness—Donepezil—Alzheimer's disease	0.000248	0.00279	CcSEcCtD
Oxymorphone—Flatulence—Rivastigmine—Alzheimer's disease	0.000247	0.00278	CcSEcCtD
Oxymorphone—Tension—Rivastigmine—Alzheimer's disease	0.000246	0.00277	CcSEcCtD
Oxymorphone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000245	0.00276	CcSEcCtD
Oxymorphone—Convulsion—Donepezil—Alzheimer's disease	0.000244	0.00275	CcSEcCtD
Oxymorphone—Hypertension—Donepezil—Alzheimer's disease	0.000243	0.00274	CcSEcCtD
Oxymorphone—Nervousness—Rivastigmine—Alzheimer's disease	0.000243	0.00274	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000243	0.00274	CcSEcCtD
Oxymorphone—Vision blurred—Memantine—Alzheimer's disease	0.000241	0.00272	CcSEcCtD
Oxymorphone—Chest pain—Donepezil—Alzheimer's disease	0.00024	0.0027	CcSEcCtD
Oxymorphone—Anxiety—Donepezil—Alzheimer's disease	0.000239	0.00269	CcSEcCtD
Oxymorphone—Vision blurred—Rivastigmine—Alzheimer's disease	0.000236	0.00266	CcSEcCtD
Oxymorphone—Agitation—Memantine—Alzheimer's disease	0.000235	0.00265	CcSEcCtD
Oxymorphone—Dry mouth—Donepezil—Alzheimer's disease	0.000235	0.00264	CcSEcCtD
Oxymorphone—Body temperature increased—Galantamine—Alzheimer's disease	0.000235	0.00264	CcSEcCtD
Oxymorphone—Abdominal pain—Galantamine—Alzheimer's disease	0.000235	0.00264	CcSEcCtD
Oxymorphone—Confusional state—Donepezil—Alzheimer's disease	0.000232	0.00261	CcSEcCtD
Oxymorphone—Methylnaltrexone—CYP2D6—Alzheimer's disease	0.000231	0.0905	CrCbGaD
Oxymorphone—Agitation—Rivastigmine—Alzheimer's disease	0.00023	0.00259	CcSEcCtD
Oxymorphone—Oedema—Donepezil—Alzheimer's disease	0.00023	0.00259	CcSEcCtD
Oxymorphone—Vertigo—Memantine—Alzheimer's disease	0.00023	0.00259	CcSEcCtD
Oxymorphone—Syncope—Memantine—Alzheimer's disease	0.000229	0.00259	CcSEcCtD
Oxymorphone—Shock—Donepezil—Alzheimer's disease	0.000226	0.00255	CcSEcCtD
Oxymorphone—Palpitations—Memantine—Alzheimer's disease	0.000226	0.00255	CcSEcCtD
Oxymorphone—Nervous system disorder—Donepezil—Alzheimer's disease	0.000226	0.00254	CcSEcCtD
Oxymorphone—Vertigo—Rivastigmine—Alzheimer's disease	0.000225	0.00253	CcSEcCtD
Oxymorphone—Loss of consciousness—Memantine—Alzheimer's disease	0.000225	0.00253	CcSEcCtD
Oxymorphone—Syncope—Rivastigmine—Alzheimer's disease	0.000224	0.00253	CcSEcCtD
Oxymorphone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000222	0.00251	CcSEcCtD
Oxymorphone—Convulsion—Memantine—Alzheimer's disease	0.000222	0.0025	CcSEcCtD
Oxymorphone—Palpitations—Rivastigmine—Alzheimer's disease	0.000221	0.00249	CcSEcCtD
Oxymorphone—Hypertension—Memantine—Alzheimer's disease	0.000221	0.00249	CcSEcCtD
Oxymorphone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00022	0.00248	CcSEcCtD
Oxymorphone—Anorexia—Donepezil—Alzheimer's disease	0.000219	0.00247	CcSEcCtD
Oxymorphone—Hypersensitivity—Galantamine—Alzheimer's disease	0.000219	0.00246	CcSEcCtD
Oxymorphone—Chest pain—Memantine—Alzheimer's disease	0.000218	0.00246	CcSEcCtD
Oxymorphone—Anxiety—Memantine—Alzheimer's disease	0.000217	0.00245	CcSEcCtD
Oxymorphone—Convulsion—Rivastigmine—Alzheimer's disease	0.000217	0.00244	CcSEcCtD
Oxymorphone—Hypertension—Rivastigmine—Alzheimer's disease	0.000216	0.00244	CcSEcCtD
Oxymorphone—Hypotension—Donepezil—Alzheimer's disease	0.000215	0.00242	CcSEcCtD
Oxymorphone—Chest pain—Rivastigmine—Alzheimer's disease	0.000213	0.0024	CcSEcCtD
Oxymorphone—Dry mouth—Memantine—Alzheimer's disease	0.000213	0.0024	CcSEcCtD
Oxymorphone—Asthenia—Galantamine—Alzheimer's disease	0.000213	0.0024	CcSEcCtD
Oxymorphone—Anxiety—Rivastigmine—Alzheimer's disease	0.000212	0.00239	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000212	0.00239	CcSEcCtD
Oxymorphone—Naloxone—ESR1—Alzheimer's disease	0.000211	0.0827	CrCbGaD
Oxymorphone—Confusional state—Memantine—Alzheimer's disease	0.000211	0.00237	CcSEcCtD
Oxymorphone—Oedema—Memantine—Alzheimer's disease	0.000209	0.00235	CcSEcCtD
Oxymorphone—Dry mouth—Rivastigmine—Alzheimer's disease	0.000208	0.00235	CcSEcCtD
Oxymorphone—Insomnia—Donepezil—Alzheimer's disease	0.000208	0.00234	CcSEcCtD
Oxymorphone—Confusional state—Rivastigmine—Alzheimer's disease	0.000206	0.00232	CcSEcCtD
Oxymorphone—Shock—Memantine—Alzheimer's disease	0.000205	0.00232	CcSEcCtD
Oxymorphone—Dyspnoea—Donepezil—Alzheimer's disease	0.000205	0.00231	CcSEcCtD
Oxymorphone—Nervous system disorder—Memantine—Alzheimer's disease	0.000205	0.00231	CcSEcCtD
Oxymorphone—Somnolence—Donepezil—Alzheimer's disease	0.000204	0.0023	CcSEcCtD
Oxymorphone—Oedema—Rivastigmine—Alzheimer's disease	0.000204	0.0023	CcSEcCtD
Oxymorphone—Tachycardia—Memantine—Alzheimer's disease	0.000204	0.0023	CcSEcCtD
Oxymorphone—Diarrhoea—Galantamine—Alzheimer's disease	0.000203	0.00229	CcSEcCtD
Oxymorphone—Skin disorder—Memantine—Alzheimer's disease	0.000203	0.00229	CcSEcCtD
Oxymorphone—Dyspepsia—Donepezil—Alzheimer's disease	0.000202	0.00228	CcSEcCtD
Oxymorphone—Hyperhidrosis—Memantine—Alzheimer's disease	0.000202	0.00228	CcSEcCtD
Oxymorphone—Shock—Rivastigmine—Alzheimer's disease	0.000201	0.00227	CcSEcCtD
Oxymorphone—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.0002	0.00226	CcSEcCtD
Oxymorphone—Decreased appetite—Donepezil—Alzheimer's disease	0.0002	0.00225	CcSEcCtD
Oxymorphone—Tachycardia—Rivastigmine—Alzheimer's disease	0.000199	0.00225	CcSEcCtD
Oxymorphone—Anorexia—Memantine—Alzheimer's disease	0.000199	0.00224	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000199	0.00224	CcSEcCtD
Oxymorphone—Skin disorder—Rivastigmine—Alzheimer's disease	0.000198	0.00224	CcSEcCtD
Oxymorphone—Fatigue—Donepezil—Alzheimer's disease	0.000198	0.00224	CcSEcCtD
Oxymorphone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000197	0.00223	CcSEcCtD
Oxymorphone—CYP3A4—nervous system—Alzheimer's disease	0.000197	0.012	CbGeAlD
Oxymorphone—Constipation—Donepezil—Alzheimer's disease	0.000197	0.00222	CcSEcCtD
Oxymorphone—Pain—Donepezil—Alzheimer's disease	0.000197	0.00222	CcSEcCtD
Oxymorphone—Dizziness—Galantamine—Alzheimer's disease	0.000196	0.00221	CcSEcCtD
Oxymorphone—Dihydrocodeine—CYP2D6—Alzheimer's disease	0.000196	0.0769	CrCbGaD
Oxymorphone—Hypotension—Memantine—Alzheimer's disease	0.000195	0.0022	CcSEcCtD
Oxymorphone—Anorexia—Rivastigmine—Alzheimer's disease	0.000195	0.00219	CcSEcCtD
Oxymorphone—CYP2D6—nervous system—Alzheimer's disease	0.000194	0.0118	CbGeAlD
Oxymorphone—Hypotension—Rivastigmine—Alzheimer's disease	0.000191	0.00215	CcSEcCtD
Oxymorphone—CYP3A4—central nervous system—Alzheimer's disease	0.00019	0.0116	CbGeAlD
Oxymorphone—Feeling abnormal—Donepezil—Alzheimer's disease	0.00019	0.00214	CcSEcCtD
Oxymorphone—Insomnia—Memantine—Alzheimer's disease	0.000189	0.00213	CcSEcCtD
Oxymorphone—Vomiting—Galantamine—Alzheimer's disease	0.000189	0.00213	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000188	0.00212	CcSEcCtD
Oxymorphone—CYP2D6—central nervous system—Alzheimer's disease	0.000187	0.0114	CbGeAlD
Oxymorphone—Dermatitis—Galantamine—Alzheimer's disease	0.000187	0.00211	CcSEcCtD
Oxymorphone—Dyspnoea—Memantine—Alzheimer's disease	0.000186	0.0021	CcSEcCtD
Oxymorphone—Headache—Galantamine—Alzheimer's disease	0.000186	0.0021	CcSEcCtD
Oxymorphone—Somnolence—Memantine—Alzheimer's disease	0.000186	0.00209	CcSEcCtD
Oxymorphone—Insomnia—Rivastigmine—Alzheimer's disease	0.000185	0.00208	CcSEcCtD
Oxymorphone—Dyspepsia—Memantine—Alzheimer's disease	0.000184	0.00207	CcSEcCtD
Oxymorphone—Hydromorphone—PTGS1—Alzheimer's disease	0.000183	0.0718	CrCbGaD
Oxymorphone—CYP2D6—cerebellum—Alzheimer's disease	0.000183	0.0111	CbGeAlD
Oxymorphone—Urticaria—Donepezil—Alzheimer's disease	0.000183	0.00206	CcSEcCtD
Oxymorphone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000182	0.00205	CcSEcCtD
Oxymorphone—Abdominal pain—Donepezil—Alzheimer's disease	0.000182	0.00205	CcSEcCtD
Oxymorphone—Body temperature increased—Donepezil—Alzheimer's disease	0.000182	0.00205	CcSEcCtD
Oxymorphone—Somnolence—Rivastigmine—Alzheimer's disease	0.000182	0.00205	CcSEcCtD
Oxymorphone—Decreased appetite—Memantine—Alzheimer's disease	0.000182	0.00205	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00018	0.00203	CcSEcCtD
Oxymorphone—Fatigue—Memantine—Alzheimer's disease	0.00018	0.00203	CcSEcCtD
Oxymorphone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00018	0.00203	CcSEcCtD
Oxymorphone—Constipation—Memantine—Alzheimer's disease	0.000179	0.00201	CcSEcCtD
Oxymorphone—Pain—Memantine—Alzheimer's disease	0.000179	0.00201	CcSEcCtD
Oxymorphone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000178	0.002	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000176	0.00199	CcSEcCtD
Oxymorphone—Nausea—Galantamine—Alzheimer's disease	0.000176	0.00199	CcSEcCtD
Oxymorphone—Fatigue—Rivastigmine—Alzheimer's disease	0.000176	0.00199	CcSEcCtD
Oxymorphone—Pain—Rivastigmine—Alzheimer's disease	0.000175	0.00197	CcSEcCtD
Oxymorphone—Constipation—Rivastigmine—Alzheimer's disease	0.000175	0.00197	CcSEcCtD
Oxymorphone—Feeling abnormal—Memantine—Alzheimer's disease	0.000172	0.00194	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000171	0.00192	CcSEcCtD
Oxymorphone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000169	0.00191	CcSEcCtD
Oxymorphone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000168	0.0019	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000167	0.00188	CcSEcCtD
Oxymorphone—Urticaria—Memantine—Alzheimer's disease	0.000166	0.00187	CcSEcCtD
Oxymorphone—Abdominal pain—Memantine—Alzheimer's disease	0.000165	0.00186	CcSEcCtD
Oxymorphone—Body temperature increased—Memantine—Alzheimer's disease	0.000165	0.00186	CcSEcCtD
Oxymorphone—Asthenia—Donepezil—Alzheimer's disease	0.000165	0.00186	CcSEcCtD
Oxymorphone—Pruritus—Donepezil—Alzheimer's disease	0.000163	0.00183	CcSEcCtD
Oxymorphone—Urticaria—Rivastigmine—Alzheimer's disease	0.000162	0.00183	CcSEcCtD
Oxymorphone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000161	0.00182	CcSEcCtD
Oxymorphone—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000161	0.00182	CcSEcCtD
Oxymorphone—Diarrhoea—Donepezil—Alzheimer's disease	0.000157	0.00177	CcSEcCtD
Oxymorphone—Hypersensitivity—Memantine—Alzheimer's disease	0.000154	0.00173	CcSEcCtD
Oxymorphone—Dizziness—Donepezil—Alzheimer's disease	0.000152	0.00171	CcSEcCtD
Oxymorphone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00015	0.0017	CcSEcCtD
Oxymorphone—Hydrocodone—CYP2D6—Alzheimer's disease	0.00015	0.059	CrCbGaD
Oxymorphone—Asthenia—Memantine—Alzheimer's disease	0.00015	0.00169	CcSEcCtD
Oxymorphone—CYP2D6—brain—Alzheimer's disease	0.000148	0.00903	CbGeAlD
Oxymorphone—Pruritus—Memantine—Alzheimer's disease	0.000148	0.00167	CcSEcCtD
Oxymorphone—Asthenia—Rivastigmine—Alzheimer's disease	0.000147	0.00165	CcSEcCtD
Oxymorphone—Vomiting—Donepezil—Alzheimer's disease	0.000146	0.00165	CcSEcCtD
Oxymorphone—Dermatitis—Donepezil—Alzheimer's disease	0.000145	0.00163	CcSEcCtD
Oxymorphone—Pruritus—Rivastigmine—Alzheimer's disease	0.000145	0.00163	CcSEcCtD
Oxymorphone—Headache—Donepezil—Alzheimer's disease	0.000144	0.00162	CcSEcCtD
Oxymorphone—Diarrhoea—Memantine—Alzheimer's disease	0.000143	0.00161	CcSEcCtD
Oxymorphone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00014	0.00158	CcSEcCtD
Oxymorphone—Dizziness—Memantine—Alzheimer's disease	0.000138	0.00156	CcSEcCtD
Oxymorphone—Oxycodone—CYP2D6—Alzheimer's disease	0.000137	0.0538	CrCbGaD
Oxymorphone—Nausea—Donepezil—Alzheimer's disease	0.000137	0.00154	CcSEcCtD
Oxymorphone—Dizziness—Rivastigmine—Alzheimer's disease	0.000135	0.00152	CcSEcCtD
Oxymorphone—Vomiting—Memantine—Alzheimer's disease	0.000133	0.0015	CcSEcCtD
Oxymorphone—Dermatitis—Memantine—Alzheimer's disease	0.000132	0.00148	CcSEcCtD
Oxymorphone—Headache—Memantine—Alzheimer's disease	0.000131	0.00147	CcSEcCtD
Oxymorphone—Vomiting—Rivastigmine—Alzheimer's disease	0.00013	0.00146	CcSEcCtD
Oxymorphone—Dermatitis—Rivastigmine—Alzheimer's disease	0.000129	0.00145	CcSEcCtD
Oxymorphone—Headache—Rivastigmine—Alzheimer's disease	0.000128	0.00144	CcSEcCtD
Oxymorphone—Buprenorphine—CYP2D6—Alzheimer's disease	0.000126	0.0496	CrCbGaD
Oxymorphone—Hydromorphone—CYP2D6—Alzheimer's disease	0.000125	0.0489	CrCbGaD
Oxymorphone—Nausea—Memantine—Alzheimer's disease	0.000124	0.0014	CcSEcCtD
Oxymorphone—Nausea—Rivastigmine—Alzheimer's disease	0.000121	0.00137	CcSEcCtD
Oxymorphone—Morphine—CYP2D6—Alzheimer's disease	0.000106	0.0415	CrCbGaD
Oxymorphone—OPRM1—Signaling by GPCR—GAB2—Alzheimer's disease	1.27e-05	0.000911	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—SST—Alzheimer's disease	1.27e-05	0.000911	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PSEN2—Alzheimer's disease	1.27e-05	0.000905	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—APP—Alzheimer's disease	1.24e-05	0.000888	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CCL2—Alzheimer's disease	1.22e-05	0.000875	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.22e-05	0.000873	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PSENEN—Alzheimer's disease	1.2e-05	0.000859	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.19e-05	0.000854	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APH1A—Alzheimer's disease	1.18e-05	0.000847	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CA4—Alzheimer's disease	1.18e-05	0.000841	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PLCB1—Alzheimer's disease	1.17e-05	0.000838	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.17e-05	0.000836	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NPY—Alzheimer's disease	1.16e-05	0.000833	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IAPP—Alzheimer's disease	1.16e-05	0.000828	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NCSTN—Alzheimer's disease	1.15e-05	0.000825	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—A2M—Alzheimer's disease	1.15e-05	0.000819	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.13e-05	0.000808	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LRP1—Alzheimer's disease	1.13e-05	0.000804	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CRH—Alzheimer's disease	1.12e-05	0.000803	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PSEN2—Alzheimer's disease	1.11e-05	0.000793	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCR5—Alzheimer's disease	1.11e-05	0.000793	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	1.11e-05	0.000791	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GFAP—Alzheimer's disease	1.1e-05	0.000786	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GAL—Alzheimer's disease	1.1e-05	0.000786	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.08e-05	0.000776	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.07e-05	0.000765	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NPS—Alzheimer's disease	1.07e-05	0.000762	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.06e-05	0.000758	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.05e-05	0.00075	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.05e-05	0.000749	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—F2—Alzheimer's disease	1.05e-05	0.000749	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTK2B—Alzheimer's disease	1.04e-05	0.000747	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.03e-05	0.000733	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NPY—Alzheimer's disease	1.02e-05	0.00073	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—GAB2—Alzheimer's disease	1.02e-05	0.000727	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SST—Alzheimer's disease	1.02e-05	0.000727	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NTRK2—Alzheimer's disease	1.02e-05	0.000727	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IAPP—Alzheimer's disease	1.02e-05	0.000726	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CALM1—Alzheimer's disease	1.01e-05	0.000724	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—GSK3A—Alzheimer's disease	1.01e-05	0.00072	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1e-05	0.000715	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—APP—Alzheimer's disease	9.9e-06	0.000708	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CRH—Alzheimer's disease	9.85e-06	0.000704	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCR5—Alzheimer's disease	9.72e-06	0.000695	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—A2M—Alzheimer's disease	9.68e-06	0.000692	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	9.59e-06	0.000686	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	9.55e-06	0.000683	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HTR2A—Alzheimer's disease	9.51e-06	0.00068	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—F2—Alzheimer's disease	9.51e-06	0.00068	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PSEN2—Alzheimer's disease	9.38e-06	0.000671	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PLCB1—Alzheimer's disease	9.35e-06	0.000668	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NPS—Alzheimer's disease	9.34e-06	0.000668	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PPP3CA—Alzheimer's disease	9.3e-06	0.000664	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	9.23e-06	0.00066	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—F2—Alzheimer's disease	9.18e-06	0.000657	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTK2B—Alzheimer's disease	9.16e-06	0.000655	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	9.05e-06	0.000647	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	9.05e-06	0.000647	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ND1—Alzheimer's disease	8.91e-06	0.000637	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—GAB2—Alzheimer's disease	8.91e-06	0.000637	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SST—Alzheimer's disease	8.91e-06	0.000637	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NTRK2—Alzheimer's disease	8.91e-06	0.000637	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CALM1—Alzheimer's disease	8.88e-06	0.000634	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	8.85e-06	0.000633	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—GSK3A—Alzheimer's disease	8.83e-06	0.000631	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NGFR—Alzheimer's disease	8.72e-06	0.000623	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APP—Alzheimer's disease	8.68e-06	0.000621	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	8.67e-06	0.00062	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CREB1—Alzheimer's disease	8.66e-06	0.000619	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NPY—Alzheimer's disease	8.63e-06	0.000617	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IAPP—Alzheimer's disease	8.58e-06	0.000613	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ADAM10—Alzheimer's disease	8.52e-06	0.000609	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCL2—Alzheimer's disease	8.48e-06	0.000606	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—F2—Alzheimer's disease	8.34e-06	0.000596	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CRH—Alzheimer's disease	8.33e-06	0.000595	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCR5—Alzheimer's disease	8.22e-06	0.000587	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PLCB1—Alzheimer's disease	8.19e-06	0.000586	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—S100B—Alzheimer's disease	8.05e-06	0.000576	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	8.04e-06	0.000575	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NPS—Alzheimer's disease	7.9e-06	0.000564	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	7.86e-06	0.000562	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—F2—Alzheimer's disease	7.76e-06	0.000555	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTK2B—Alzheimer's disease	7.74e-06	0.000553	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CA4—Alzheimer's disease	7.69e-06	0.00055	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IGF2—Alzheimer's disease	7.67e-06	0.000548	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NGFR—Alzheimer's disease	7.65e-06	0.000547	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CREB1—Alzheimer's disease	7.6e-06	0.000543	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NTRK2—Alzheimer's disease	7.53e-06	0.000538	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SST—Alzheimer's disease	7.53e-06	0.000538	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GAB2—Alzheimer's disease	7.53e-06	0.000538	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CALM1—Alzheimer's disease	7.5e-06	0.000536	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ADAM10—Alzheimer's disease	7.47e-06	0.000534	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GSK3A—Alzheimer's disease	7.47e-06	0.000534	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCL2—Alzheimer's disease	7.43e-06	0.000531	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IGF1R—Alzheimer's disease	7.41e-06	0.00053	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APP—Alzheimer's disease	7.34e-06	0.000525	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	7.23e-06	0.000517	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—LPL—Alzheimer's disease	7.11e-06	0.000508	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—S100B—Alzheimer's disease	7.06e-06	0.000505	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—F2—Alzheimer's disease	7.05e-06	0.000504	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MEF2C—Alzheimer's disease	7.04e-06	0.000504	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PLCB1—Alzheimer's disease	6.93e-06	0.000495	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PRKCG—Alzheimer's disease	6.91e-06	0.000494	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	6.85e-06	0.00049	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NGF—Alzheimer's disease	6.73e-06	0.000481	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IGF2—Alzheimer's disease	6.72e-06	0.000481	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCR5—Alzheimer's disease	6.55e-06	0.000468	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PLD3—Alzheimer's disease	6.54e-06	0.000467	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IGF1R—Alzheimer's disease	6.5e-06	0.000465	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NGFR—Alzheimer's disease	6.46e-06	0.000462	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CREB1—Alzheimer's disease	6.42e-06	0.000459	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HTR2A—Alzheimer's disease	6.41e-06	0.000458	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ADAM10—Alzheimer's disease	6.31e-06	0.000451	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCL2—Alzheimer's disease	6.28e-06	0.000449	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	6.27e-06	0.000448	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—LPL—Alzheimer's disease	6.23e-06	0.000446	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MEF2C—Alzheimer's disease	6.18e-06	0.000442	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PRKCG—Alzheimer's disease	6.06e-06	0.000433	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	6.04e-06	0.000431	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CALM1—Alzheimer's disease	5.98e-06	0.000427	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—S100B—Alzheimer's disease	5.97e-06	0.000427	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—LEP—Alzheimer's disease	5.96e-06	0.000426	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—APOE—Alzheimer's disease	5.96e-06	0.000426	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NGF—Alzheimer's disease	5.9e-06	0.000422	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CAV1—Alzheimer's disease	5.9e-06	0.000422	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ND1—Alzheimer's disease	5.83e-06	0.000417	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—TPI1—Alzheimer's disease	5.74e-06	0.000411	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CHAT—Alzheimer's disease	5.74e-06	0.000411	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCR5—Alzheimer's disease	5.74e-06	0.000411	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ESR1—Alzheimer's disease	5.69e-06	0.000407	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF2—Alzheimer's disease	5.68e-06	0.000406	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HTR2A—Alzheimer's disease	5.62e-06	0.000402	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—F2—Alzheimer's disease	5.62e-06	0.000402	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MAOB—Alzheimer's disease	5.51e-06	0.000394	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	5.5e-06	0.000393	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF1R—Alzheimer's disease	5.49e-06	0.000393	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	5.3e-06	0.000379	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LPL—Alzheimer's disease	5.27e-06	0.000377	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CALM1—Alzheimer's disease	5.24e-06	0.000375	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—LEP—Alzheimer's disease	5.22e-06	0.000373	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APOE—Alzheimer's disease	5.22e-06	0.000373	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MEF2C—Alzheimer's disease	5.22e-06	0.000373	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CAV1—Alzheimer's disease	5.18e-06	0.00037	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—GSK3B—Alzheimer's disease	5.16e-06	0.000369	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PRKCG—Alzheimer's disease	5.12e-06	0.000366	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—A2M—Alzheimer's disease	5.12e-06	0.000366	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CREB1—Alzheimer's disease	5.12e-06	0.000366	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—INS—Alzheimer's disease	5.09e-06	0.000364	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCL2—Alzheimer's disease	5.01e-06	0.000358	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NGF—Alzheimer's disease	4.99e-06	0.000357	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ESR1—Alzheimer's disease	4.99e-06	0.000357	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—F2—Alzheimer's disease	4.93e-06	0.000352	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IGF1—Alzheimer's disease	4.92e-06	0.000352	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCR5—Alzheimer's disease	4.85e-06	0.000347	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.82e-06	0.000345	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HTR2A—Alzheimer's disease	4.75e-06	0.00034	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—GSK3B—Alzheimer's disease	4.52e-06	0.000323	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CREB1—Alzheimer's disease	4.49e-06	0.000321	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOS3—Alzheimer's disease	4.46e-06	0.000319	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—INS—Alzheimer's disease	4.46e-06	0.000319	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ACHE—Alzheimer's disease	4.45e-06	0.000318	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CALM1—Alzheimer's disease	4.43e-06	0.000317	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LEP—Alzheimer's disease	4.42e-06	0.000316	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APOE—Alzheimer's disease	4.42e-06	0.000316	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	4.4e-06	0.000315	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCL2—Alzheimer's disease	4.39e-06	0.000314	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CAV1—Alzheimer's disease	4.37e-06	0.000313	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IGF1—Alzheimer's disease	4.32e-06	0.000309	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ESR1—Alzheimer's disease	4.22e-06	0.000301	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ENO1—Alzheimer's disease	4.17e-06	0.000298	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	4.17e-06	0.000298	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—F2—Alzheimer's disease	4.16e-06	0.000298	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.07e-06	0.000291	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOS3—Alzheimer's disease	3.91e-06	0.00028	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—BCHE—Alzheimer's disease	3.88e-06	0.000277	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.82e-06	0.000273	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GSK3B—Alzheimer's disease	3.82e-06	0.000273	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CREB1—Alzheimer's disease	3.79e-06	0.000271	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CASP3—Alzheimer's disease	3.79e-06	0.000271	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—INS—Alzheimer's disease	3.77e-06	0.00027	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—Alzheimer's disease	3.77e-06	0.000269	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—TPI1—Alzheimer's disease	3.76e-06	0.000268	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CHAT—Alzheimer's disease	3.76e-06	0.000268	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL2—Alzheimer's disease	3.71e-06	0.000265	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	3.66e-06	0.000262	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF1—Alzheimer's disease	3.65e-06	0.000261	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MAOB—Alzheimer's disease	3.6e-06	0.000257	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	3.55e-06	0.000254	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK8—Alzheimer's disease	3.48e-06	0.000249	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AKT1—Alzheimer's disease	3.47e-06	0.000248	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	3.47e-06	0.000248	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.35e-06	0.00024	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—A2M—Alzheimer's disease	3.35e-06	0.000239	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CASP3—Alzheimer's disease	3.32e-06	0.000238	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	3.31e-06	0.000236	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—Alzheimer's disease	3.3e-06	0.000236	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—VEGFA—Alzheimer's disease	3.22e-06	0.00023	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.06e-06	0.000219	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK8—Alzheimer's disease	3.05e-06	0.000218	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AKT1—Alzheimer's disease	3.05e-06	0.000218	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.05e-06	0.000218	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TGFB1—Alzheimer's disease	2.95e-06	0.000211	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.91e-06	0.000208	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.88e-06	0.000206	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.83e-06	0.000203	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—VEGFA—Alzheimer's disease	2.82e-06	0.000202	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	2.81e-06	0.000201	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	2.79e-06	0.000199	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.78e-06	0.000199	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.73e-06	0.000195	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.73e-06	0.000195	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.68e-06	0.000191	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TGFB1—Alzheimer's disease	2.59e-06	0.000185	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	2.58e-06	0.000185	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	2.57e-06	0.000184	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.54e-06	0.000181	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.51e-06	0.000179	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TP53—Alzheimer's disease	2.43e-06	0.000174	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.39e-06	0.000171	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	2.38e-06	0.00017	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.34e-06	0.000167	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.33e-06	0.000167	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.32e-06	0.000166	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.31e-06	0.000165	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—Alzheimer's disease	2.22e-06	0.000159	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	2.19e-06	0.000156	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TP53—Alzheimer's disease	2.13e-06	0.000152	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AKT1—Alzheimer's disease	2.05e-06	0.000147	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.03e-06	0.000145	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2e-06	0.000143	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—INS—Alzheimer's disease	1.99e-06	0.000143	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.99e-06	0.000142	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—Alzheimer's disease	1.95e-06	0.000139	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.82e-06	0.00013	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	1.8e-06	0.000129	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AKT1—Alzheimer's disease	1.8e-06	0.000129	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.75e-06	0.000125	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	1.65e-06	0.000118	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.64e-06	0.000117	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.6e-06	0.000114	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.53e-06	0.000109	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.53e-06	0.000109	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.52e-06	0.000109	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.51e-06	0.000108	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.33e-06	9.5e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—INS—Alzheimer's disease	1.3e-06	9.32e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.14e-06	8.17e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.05e-06	7.48e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AKT1—Alzheimer's disease	8.04e-07	5.75e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	5.26e-07	3.76e-05	CbGpPWpGaD
